Homepage
Medication Guide
Indications of Ramelteon
Ramelteon is developed and produced by Takeda Pharmaceutical Company. As a selective agonist of MT1 and MT2 melatonin receptors, it regulates the sleep-wake cycle by simulating the mechanism of action...
510
Thursday, September 18th, 2025, 16:39
What are the side effects of Natalizumab?
Natalizumab is a monoclonal antibody drug used in the treatment of relapsing forms of multiple sclerosis (MS). It exerts its effect by inhibiting α4-integrin-mediated migration of immune cells. Despit...
510
Thursday, September 18th, 2025, 16:34
How Effective is Natalizumab in Treatment?
Natalizumab is a recombinant humanized IgG4κ monoclonal antibody. As a crucial drug in the field of multiple sclerosis (MS) treatment, its unique α4-integrin inhibitory effect provides patients with a...
507
Thursday, September 18th, 2025, 16:31
Precautions for Natalizumab Administration
Natalizumab is a recombinant humanized monoclonal antibody targeting α4-integrin. It exerts its therapeutic effect by inhibiting the migration of immune cells, but may trigger severe immune-related ad...
509
Thursday, September 18th, 2025, 16:28
How to Use Natalizumab
Natalizumab is a humanized monoclonal antibody targeting α4-integrin, indicated for the treatment of relapsing forms of multiple sclerosis (MS).How to Use NatalizumabStandard Administration RegimenDos...
511
Thursday, September 18th, 2025, 16:20
Indications of Natalizumab
Natalizumab is an important biologic agent produced by Biogen Idec. As a recombinant humanized IgG4κ monoclonal antibody, this drug has demonstrated good efficacy in the treatment of specific diseases...
512
Thursday, September 18th, 2025, 16:13
Precautions for Cemiplimab Administration
Cemiplimab is a PD-1 inhibitor indicated for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) in patients who are not suitable for curative surgery or radiother...
508
Thursday, September 18th, 2025, 16:10
How to Use Cemiplimab
Cemiplimab is a monoclonal antibody targeting PD-1, indicated for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) that cannot be cured by surgery or radiothera...
508
Thursday, September 18th, 2025, 16:04
Indications of Cemiplimab
Cemiplimab is a programmed death receptor-1 (PD-1) blocking antibody that activates the immune system to fight against tumors by inhibiting the PD-1/PD-L1 pathway.Indications of CemiplimabCore Indicat...
509
Thursday, September 18th, 2025, 15:59
How Effective is Emicizumab in Treatment?
As an innovative therapeutic agent, Emicizumab has demonstrated considerable value in the field of hemophilia A treatment in recent years.How Effective is Emicizumab in Treatment?Bleeding Prevention E...
507
Thursday, September 18th, 2025, 15:47
120 / 215
2143 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved